A Transparent PBM Is a Contract, Not a Label
Nearly every pharmacy benefit manager can put the word “transparent” in a presentation.
The harder question is whether the employer can follow every dollar after the contract is signed.
For CEOs and CFOs running a self-funded health plan, PBM transparency is not a personality trait. It is a set of contract rights, data fields, financial definitions, and audit remedies.
The Source Idea in Plain English
The U.S. Department of Labor proposed a PBM fee disclosure rule in January 2026 and extended the comment period after Congress added pharmacy-benefit provisions to ERISA. The proposal focuses on a basic fiduciary problem: self-funded plan leaders cannot judge whether a PBM arrangement is reasonable if they cannot see how the PBM and its affiliates are paid.
The proposed disclosures would give plan fiduciaries more detail about direct and indirect compensation, including money connected to manufacturers, pharmacies, rebate aggregators, and related companies. The point is not to make every employer a pharmacy economist. The point is to give the employer enough information to identify conflicts, compare arrangements, and ask whether the compensation is reasonable.
A May 2026 Pennsylvania Insurance Department study adds a practical market signal. The department reported movement away from spread pricing and toward more transparent pricing models in the fully insured market it studied. That is useful intelligence for Midwest employers even though state rules do not apply to every self-funded plan in the same way.
The business idea is simple: transparency should reveal the economic model, not merely rename it.
Why This Matters More in Self-Funding
In a fully insured plan, the employer pays a premium and the insurer bears the claim risk. In a self-funded plan, the employer's money pays the claims. The PBM may negotiate drug prices, build the formulary, operate a pharmacy network, collect rebates, use affiliated companies, and decide how transactions are reported.
That gives the PBM influence over one of the fastest-moving parts of the health plan budget. It also means a low administrative fee can be a distraction if the PBM earns money elsewhere in the transaction.
The employer needs to understand at least four money flows:
- What the plan pays the PBM for a prescription.
- What the PBM or its affiliate pays the dispensing pharmacy.
- What the PBM, rebate aggregator, or group purchasing organization receives from manufacturers.
- What portion of those amounts returns to the plan, and when.
If those numbers cannot be reconciled, the plan does not yet have financial transparency.
Spread Pricing Is Only One Test
Spread pricing happens when the PBM charges the plan more for a prescription than it reimburses the pharmacy and keeps the difference. A pass-through contract is generally supposed to charge the plan the same ingredient cost and dispensing fee paid to the pharmacy, with the PBM earning a stated administrative fee.
That distinction matters, but it is not the whole test.
A contract can say “pass-through” while using definitions, affiliate arrangements, specialty-pharmacy pricing, rebate guarantees, or excluded revenue categories that preserve other sources of compensation. A plan can also receive reports that are technically detailed but impossible to reconcile to claims and invoices.
The leadership question is not, “Did the proposal say pass-through?” It is, “Can our team prove pass-through using the contract, claim file, pharmacy payment data, and rebate report?”
Five Contract Rights That Make Transparency Real
1. Complete compensation definitions. The agreement should define rebates, fees, discounts, credits, price concessions, data payments, manufacturer revenue, affiliate revenue, and other forms of direct or indirect compensation. Undefined money has a way of disappearing from the employer's view.
2. Drug-level reporting. Totals are not enough. The employer should be able to connect National Drug Codes, quantities, dates, pharmacies, plan-paid amounts, member cost sharing, and applicable rebate information. Privacy protections still matter, but they should not erase the financial record.
3. Clear affiliate disclosure. If the PBM uses an affiliated specialty pharmacy, mail-order pharmacy, rebate aggregator, or purchasing organization, the employer should know the role of that entity and how it is compensated.
4. A usable audit right. An audit clause should say who can audit, which records are available, how often an audit can occur, how far back it can look, and what happens when an error is found. A right that excludes the important records is decoration.
5. Ownership and portability of data. The employer should be able to obtain its claim and utilization data in a usable format during the contract and after termination. Otherwise, the cost of leaving can become part of the vendor's leverage.
Do Not Confuse More Data With a Better Decision
New disclosure rules can improve the employer's position. They do not automatically improve the employer's process.
A six-hundred-column file is not transparency if no one tests it. A rebate report is not transparency if it cannot be matched to the contract guarantee. An audit is not oversight if the findings never reach the people making the renewal decision.
Before renewal, finance and benefits leaders should turn the information into three answers:
- What did the PBM and its related entities earn?
- What did the plan receive in return?
- Which contract change would improve cost, control, or member access next year?
That is the difference between receiving data and governing a plan.
Where Superior Insurance Advisors Fits
Superior Insurance Advisors helps CEOs, CFOs, and business owners connect PBM contract language to pharmacy claims, rebate reports, renewal projections, and the larger self-funded plan strategy.
That work is not about declaring one PBM model perfect for every employer. It is about making the economics visible enough to compare choices and document a responsible decision.
Paul.Health provides a practical place to organize the questions, documents, and next steps before the renewal deadline compresses the conversation into a sales presentation.
A Practical PBM Transparency Checklist
- List every way the PBM and its affiliates can be compensated.
- Confirm whether pharmacy reimbursement and plan charges can be reconciled.
- Identify every rebate, discount, fee, and credit that is passed through or retained.
- Review specialty-pharmacy, mail-order, formulary, and affiliate incentives.
- Test the audit clause against the records an auditor would actually need.
- Confirm the plan owns and can export its claims and utilization data.
- Put unresolved differences and the final decision in the fiduciary file.
The decision question for leadership is: if your PBM calls itself transparent, can your company independently reconcile what the plan paid, what the pharmacy received, what every related entity earned, and what came back to the plan?